Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 17.60
-0.26 (-1.46%)
May 20, 2026, 11:34 AM CST
SHE:000623 Market Cap
SHE:000623 has a market cap or net worth of 20.94 billion as of May 19, 2026. Its market cap has increased by 12.09% in one year.
Market Cap
20.94B
Enterprise Value
20.51B
Revenue
2.23B
Ranking
n/a
PE Ratio
7.63
Stock Price
17.60
Market Cap Chart
Since April 11, 2006, SHE:000623's market cap has increased from 2.63B to 20.94B, an increase of 697.37%. That is a compound annual growth rate of 10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 20.94B | -8.55% |
| Dec 31, 2025 | 22.90B | 10.86% |
| Dec 31, 2024 | 20.65B | 20.79% |
| Dec 29, 2023 | 17.10B | 0.46% |
| Dec 30, 2022 | 17.02B | -19.09% |
| Dec 31, 2021 | 21.03B | 10.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangmei Pharmaceutical | 22.40B |
| Walvax Biotechnology | 22.36B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 21.90B |
| Hybio Pharmaceutical | 21.47B |
| Tasly Pharmaceutical Group | 21.47B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.43B |
| Betta Pharmaceuticals | 21.27B |
| Chengdu Kanghong Pharmaceutical Group | 19.80B |